PFA-100 System: A New Method for Assessment of Platelet Dysfunction.

Area of Science:

• Hematology
• Clinical Pathology

Background:

• Platelet function analyzers are crucial for diagnosing hemostasis disorders.
• The PFA-100 system utilizes collagen/epinephrine (CEPI) and collagen/ADP (CADP) cartridges to assess platelet function.
• Previous studies indicated CEPI cartridges detect aspirin-induced defects, while CADP cartridges identify thrombocytopathies.

Purpose of the Study:

• To evaluate the diagnostic performance of the PFA-100 system in identifying various platelet function defects.
• To compare the PFA-100 system's accuracy against traditional platelet aggregometry.
• To establish reference intervals for the PFA-100 system's CEPI and CADP cartridges.

Main Methods:

• A seven-center trial involving 206 healthy subjects and 176 patients with platelet defects, including 127 aspirin users.
• Comparison of PFA-100 results with a comprehensive platelet function test panel and platelet aggregometry.
• Analysis of sensitivity, specificity, and concordance between the two testing methods.

Main Results:

• The PFA-100 system demonstrated high clinical sensitivity (94.9%) and specificity (88.8%), comparable to aggregometry (94.3% sensitivity, 88.3% specificity).
• The system effectively identified aspirin-induced defects (94.5% sensitivity) and congenital thrombocytopathies (95.9% sensitivity).
• Overall agreement between PFA-100 and aggregometry was 87.5% (Kappa index 0.751), indicating equivalent diagnostic capabilities.

Conclusions:

• The PFA-100 system is a highly accurate and reliable instrument for assessing platelet function.
• Its ease of use makes it a valuable tool for screening patients with suspected platelet-related hemostasis defects.
• The PFA-100 system offers comparable diagnostic performance to platelet aggregometry.